Stem Cell Therapeutics Corp. Announces Publication of Phase IIa Stroke Data
CALGARY, ALBERTA–(Marketwire – 03/10/10) – Stem Cell Therapeutics Corp. (”SCT” or the “Company”) (TSX-V: SSS – News ) wishes to announce the acceptance and publication of the paper entitled “The Beta-hCG + Erythropoietin in Acute Stroke ( BETAS) Study” by the journal “Stroke”, on March 8, 2010. This paper was authored by Dr. Steven C. Cramer, from the University of California, Irvine, Dr. David …
[Read the full article here]Related News:
Stem Cell Therapeutics Corp. Announces Publication of …
Stem Cell Therapeutics Corp. Announces Presentation of Modified REGENESIS Trial Results at the International Stroke …
Stem Cell Therapeutics Corp. Announces Publication of Phase IIa Stroke …